We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

GMAB

Market closed
Access this stock data via API
Subscribe
Genmab A/S
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 21.5B 16.5B 14.5B 8.4B
Cost of revenue 985M 226M 0 0
Gross profit 20.5B 16.2B 14.5B 8.4B
Operating expense
Research & development 9.7B 7.6B 5.6B 4.2B
Selling general and admin 3.8B 3.3B 2.7B 1.3B
Other operating expenses
Operating income 7.0B 5.3B 6.3B 3.0B
Non operating interest income
Income 995M 939M 324M 197M
Expense 120M 27M 21M 13M
Other income expense 1.3B -596M 375M 781M
Pretax income 9.2B 5.6B 6.9B 3.9B
Tax provision 1.3B 1.3B 1.5B 961M
Net income 7.8B 4.4B 5.5B 3.0B
Basic EPS 122.2 66.6 84.5 46
Diluted EPS 121.4 66.0 83.7 45.5
Basic average shares 422.2M 65.3M 65.8M 65.6M
Diluted average shares 422.2M 65.3M 65.8M 65.6M
EBITDA 8.4B 6.6B 7.0B 3.4B
Net income from continuing op. 9.2B 5.6B 6.9B 3.9B
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed (non-working day)
Main market opens in 2 days 8 hours 8 minutes

00:51
00:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:00
All times are displayed in the Europe/Copenhagen timezone (CEST, UTC+02:00).